sur B.R.A.I.N. Biotechnology Research And Information Network AG (ETR:DE000520)
BRAIN Biotech AG 2026 AGM Results
On March 11, 2026, BRAIN Biotech AG held its Annual General Meeting in Zwingenberg, Germany. Shareholders approved all agenda items with a broad majority. Dr. Ursula La Cognata, previously appointed by the Darmstadt Local Court, was elected to the Supervisory Board for four years. Chairman Dr. Michael Majerus posited positive development opportunities due to the company's strong market position and innovations from the BRAINBioIncubator.
CEO Adriaan Moelker emphasized the two-pillar strategy of BRAINBiocatalysts and BRAINBioIncubator as key to expanding its enzyme-focused business. The company will consolidate enzyme production and sales in the Netherlands, including a new baking application center nearing completion.
Shareholder participation represented 61.82% of the share capital. Detailed results are available on the company's website.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de B.R.A.I.N. Biotechnology Research And Information Network AG